You searched for "Nigeria"

404 results found

Ocular manifestations of Whipple’s disease

In this retrospective review of 217 patients with Whipple’s disease (WD), the authors reviewed the presentations of those with ocular manifestations. Ocular signs of WD are under recognised, frequently resulting in misdiagnosis and mismanagement. Mayo Data Explorer, a Mayo Clinic...

Does the length of the school day have a role in age of myopia onset?

The authors prospectively collected the refractive data of myopic adults attending recruiting dispensing optician or ophthalmologist sites. Participants were recruited consecutively, giving verbal informed consent. Sites included a mix of urban and rural areas across eight sites. The following data...

Improved quality of life in children with allergic conjunctivitis and their parents with anti-allergic therapy

This prospective intervention study investigated the change in quality of life in child-parent pairs with allergic conjunctivitis (AC) on anti-allergic therapy. From September 2020 to May 2021, AC child-parent pairs and healthy child-parent pairs were recruited in Guangzhou, China. Children...

Narrative literature review for intermittent exotropia

This is a narrative literature review on prevalence, terminology, risk factors, natural history and clinical characteristics for intermittent exotropia. A Medline search was conducted with no date restrictions up to September 2020 and collating English language studies. Prevalence was reported...

Chandelier-assisted versus standard scleral buckling for rhegmatogenous retinal detachment repair. Systematic review and meta-analysis

Despite a significant global decline in standard scleral buckling (SSB) procedures for rhegmatogenous retinal detachment (RRD), it continues to hold its place as an essential treatment option, offering distinct advantages such as cost-effectiveness, preservation of the vitreous, improved final visual...

Outcomes in intermediate age-related macular degeneration (AMD): A MACUSTAR study report

Intermediate AMD (iAMD) is the most high-risk AMD stage for progressing to late AMD. This article gives the report of the MACUSTAR study. A wide range of assessments were conducted across 20 sites in seven European countries, in accordance with...

SightCare Awards 2026 – celebrating excellence in independent optometry

The SightCare Awards 2026 are now open for entries - and this year, they’re bigger, bolder and more prestigious than ever. Set against the stunning backdrop of Edgbaston Stadium, Birmingham, the SightCare Awards return in black-tie style on Sunday 26...

Vision for the future: Changes to Glaucoma UK’s research programme in 2025

Glaucoma UK is excited to announce a new, reshaped Research Grants Programme for 2025. Set to open in January, this programme aims to support innovative research to improve the understanding, treatment, and care of glaucoma. Alongside opportunities for researchers at...

Acute retinal necrosis presumably caused by Epstein-Barr virus infection

Acute retinal necrosis (ARN) is an uncommon, but serious and potentially blinding condition. ARN is characterised by panuveitis, occlusive vasculopathy and progressive peripheral necrotising retinitis. The diagnosis is clinical but confirmation is sought via aqueous and vitreous sampling. Varicella zoster...

Vision Care for Homeless People

Vison Care for Homeless People (VCHP) was first established in 2003 with the aim to provide eye tests and glasses free of charge to people living in shelters, hostels or who are sleeping rough. Today, we remain the only national...

Applying for ophthalmology ST1 in 2026: What’s new?

Competition for ophthalmology ST1 has intensified steadily over recent cycles, rising from ~9:1 (2022) to ~10:1 (2023), ~14:1 (2024) and ~22:1 (2025) [1]. Against this background, applicants benefit from a structured approach: mapping achievements to portfolio domains early, identifying gaps...

Update on emerging therapies for age-related macular degeneration

The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...